Revenue contracted by 10.9% year-over-year in 2026Q1, while gross margins remain pressured, fluctuating between 15.5% and 24.5% over the last ten quarters.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Sales/Revenue | 386.38M | 397.23M | 443.22M | 565.23M | 690.81M | 643.89M | 486.41M | 545.97M | 575.87M | 588.15M | 538.54M | 499.51M | 447.4M | 356.55M | 296.56M | 259.67M |
| Revenue Growth % | -8.98% | -10.38% | -21.59% | -18.18% | 7.29% | 32.38% | -10.91% | -5.19% | -2.09% | 9.21% | 7.81% | 11.65% | 25.48% | 20.23% | 14.21% | - |
| Cost of Goods Sold | 314.48M | 323.95M | 346.55M | 473.29M | 527.56M | 472.39M | 352.47M | 397.33M | 412.46M | 390.92M | 326.06M | 299.29M | 257.75M | 194.44M | 169.17M | 155.38M |
| COGS % of Revenue | - | 81.55% | 78.19% | 83.73% | 76.37% | 73.37% | 72.46% | 72.78% | 71.62% | 66.47% | 60.54% | 59.92% | 57.61% | 54.53% | 57.04% | 59.84% |
| Gross Profit | 71.9M | 73.28M | 96.67M | 91.94M | 163.25M | 171.5M | 133.94M | 148.64M | 163.41M | 197.22M | 212.49M | 200.22M | 189.65M | 162.12M | 127.39M | 104.29M |
| Gross Margin % | 18.61% | 18.45% | 21.81% | 16.27% | 23.63% | 26.63% | 27.54% | 27.22% | 28.38% | 33.53% | 39.46% | 40.08% | 42.39% | 45.47% | 42.96% | 40.16% |
| Gross Profit Growth % | - | -24.2% | 5.15% | -43.68% | -4.81% | 28.04% | -9.89% | -9.04% | -17.14% | -7.18% | 6.12% | 5.58% | 16.98% | 27.26% | 22.15% | - |
| Operating Expenses | 126.76M | 124.68M | 138.56M | 179.97M | 221.93M | 144.07M | 111.42M | 123.96M | 121.74M | 131.88M | 113.81M | 99.19M | 94.61M | 86.11M | 77.43M | 66.55M |
| OpEx % of Revenue | - | 31.39% | 31.26% | 31.84% | 32.13% | 22.37% | 22.91% | 22.7% | 21.14% | 22.42% | 21.13% | 19.86% | 21.15% | 24.15% | 26.11% | 25.63% |
| Selling, General & Admin | 117.16M | 119.01M | 125.36M | 131.71M | 146.01M | 136.57M | 101.13M | 107.45M | 118.11M | 127.72M | 110.52M | 96.13M | 91.98M | 84.11M | 75.33M | 64.06M |
| SG&A % of Revenue | - | 29.96% | 28.28% | 23.3% | 21.14% | 21.21% | 20.79% | 19.68% | 20.51% | 21.72% | 20.52% | 19.25% | 20.56% | 23.59% | 25.4% | 24.67% |
| Research & Development | 5.61M | 5.67M | 4.95M | 5.09M | 4.1M | 4.22M | 3.97M | 4.15M | 3.63M | 4.16M | 3.29M | 3.05M | 2.63M | 2M | 2.1M | 2.49M |
| R&D % of Revenue | - | 1.43% | 1.12% | 0.9% | 0.59% | 0.65% | 0.82% | 0.76% | 0.63% | 0.71% | 0.61% | 0.61% | 0.59% | 0.56% | 0.71% | 0.96% |
| Other Operating Expenses | 1000K | 0 | 8.25M | 43.17M | 71.83M | 3.28M | 6.32M | 12.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -54.86M | -51.4M | -41.89M | -88.03M | -58.69M | 27.43M | 22.52M | 24.68M | 32.77M | 40.54M | 92.8M | 96.39M | 95.04M | 76M | 49.96M | 37.75M |
| Operating Margin % | -14.2% | -12.94% | -9.45% | -15.57% | -8.5% | 4.26% | 4.63% | 4.52% | 5.69% | 6.89% | 17.23% | 19.3% | 21.24% | 21.32% | 16.85% | 14.54% |
| Operating Income Growth % | - | -22.72% | 52.42% | -50% | -313.96% | 21.79% | -8.76% | -24.67% | -19.18% | -56.31% | -3.72% | 1.41% | 25.05% | 52.12% | 32.36% | - |
| EBITDA | -42.29M | -37.2M | -24.75M | -58.02M | -22.34M | 62.84M | 51.98M | 53.27M | 61.36M | 70.47M | 121.06M | 118.72M | 112.22M | 91M | 64.33M | 52.36M |
| EBITDA Margin % | -10.94% | -9.37% | -5.58% | -10.27% | -3.23% | 9.76% | 10.69% | 9.76% | 10.65% | 11.98% | 22.48% | 23.77% | 25.08% | 25.52% | 21.69% | 20.16% |
| EBITDA Growth % | -22.03% | -50.3% | 57.34% | -159.68% | -135.56% | 20.88% | -2.42% | -13.18% | -12.93% | -41.79% | 1.97% | 5.79% | 23.32% | 41.46% | 22.86% | - |
| D&A (Non-Cash Add-back) | 12.57M | 14.2M | 17.13M | 30.01M | 36.34M | 35.41M | 29.46M | 28.59M | 28.59M | 29.93M | 28.25M | 22.33M | 17.18M | 14.99M | 14.37M | 14.62M |
| EBIT | -138.06M | -51.4M | -37.75M | -81.63M | -49.88M | 26.58M | 16.63M | 23.02M | 43.77M | 65.34M | 98.67M | 101.04M | 95.27M | 72.73M | 49.13M | 34.75M |
| Net Interest Income | -6.89M | 507K | 653K | -3.75M | -5.42M | -6.18M | -3.44M | -2.89M | -2.7M | -3.09M | -3.74M | -3.35M | -3.37M | -1.69M | -1.43M | -1.49M |
| Interest Income | 0 | 3.15M | 4.8M | 1.58M | 307K | 554K | 870K | 1.02M | 1.47M | 1.03M | 152K | 77K | 403K | 655K | 520K | 286K |
| Interest Expense | 6.89M | 2.64M | 4.15M | 5.33M | 5.73M | 6.74M | 4.31M | 3.91M | 4.18M | 4.13M | 3.9M | 3.43M | 3.77M | 2.35M | 1.95M | 1.77M |
| Other Income/Expense | -86.87M | -82.07M | -9K | 1.07M | 3.08M | -7.59M | -10.2M | -5.58M | -3.64M | -5.58M | -3.32M | -3.08M | -1.04M | -1.31M | -2.77M | -4.78M |
| Pretax Income | -141.72M | -133.47M | -41.9M | -86.96M | -55.61M | 19.84M | 12.32M | 19.11M | 29.13M | 34.96M | 89.49M | 93.3M | 93.99M | 74.69M | 47.19M | 32.97M |
| Pretax Margin % | -36.68% | -33.6% | -9.45% | -15.38% | -8.05% | 3.08% | 2.53% | 3.5% | 5.06% | 5.94% | 16.62% | 18.68% | 21.01% | 20.95% | 15.91% | 12.7% |
| Income Tax | 4.15M | 4.28M | 1.08M | 21.28M | 758K | 1.95M | 4.7M | 6.24M | 4.56M | 7.4M | 13M | 13.84M | 13.74M | 10.34M | 6.82M | 3.6M |
| Effective Tax Rate % | -2.93% | -3.21% | -2.58% | -24.47% | -1.36% | 9.83% | 38.14% | 32.68% | 15.66% | 21.17% | 14.53% | 14.84% | 14.62% | 13.84% | 14.45% | 10.92% |
| Net Income | -145.69M | -137.47M | -42.83M | -107.66M | -57.05M | 18.97M | 7.22M | 12.86M | 24.41M | 26.2M | 74.6M | 77.77M | 78.44M | 63.34M | 39.63M | 29.05M |
| Net Margin % | -37.71% | -34.61% | -9.66% | -19.05% | -8.26% | 2.95% | 1.48% | 2.36% | 4.24% | 4.46% | 13.85% | 15.57% | 17.53% | 17.77% | 13.36% | 11.19% |
| Net Income Growth % | -187.78% | -220.94% | 60.21% | -88.69% | -400.82% | 162.76% | -43.88% | -47.3% | -6.86% | -64.87% | -4.08% | -0.85% | 23.83% | 59.83% | 36.42% | - |
| Net Income (Continuing) | -145.88M | -137.76M | -42.98M | -108.24M | -56.37M | 17.89M | 7.62M | 12.86M | 24.57M | 27.56M | 76.48M | 79.46M | 80.26M | 64.35M | 40.37M | 29.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | -3.39M | 2.2M | 2.32M | 2.28M | 2.11M | -5.59M | -5.59M | 16.48M | 10.69M | 8.84M | 8.71M | 7.62M | 7.11M | 6.21M |
| EPS (Diluted) | -4.21 | -3.98 | -1.13 | -3.13 | -1.63 | 0.55 | 0.21 | 0.37 | 0.71 | 0.73 | 2.08 | 2.19 | 2.22 | 1.80 | 1.21 | 1.48 |
| EPS Growth % | -209.56% | -252.21% | 63.9% | -92.02% | -396.36% | 161.9% | -43.24% | -47.89% | -2.74% | -64.9% | -5.02% | -1.35% | 23.33% | 48.76% | -18.24% | - |
| EPS (Basic) | - | -3.98 | -1.13 | -3.13 | -1.63 | 0.55 | 0.21 | 0.37 | 0.71 | 0.73 | 2.08 | 2.21 | 2.25 | 1.83 | 1.21 | 1.48 |
| Diluted Shares Outstanding | 34.58M | 34.57M | 34.54M | 34.52M | 34.49M | 34.57M | 34.47M | 34.46M | 34.41M | 34.39M | 34.76M | 35.46M | 35.39M | 35.21M | 32.7M | 19.57M |
| Basic Shares Outstanding | 34.58M | 34.57M | 34.54M | 34.52M | 34.49M | 34.46M | 34.42M | 34.38M | 34.36M | 34.33M | 34.71M | 35.25M | 34.93M | 34.67M | 32.64M | 19.57M |
| Dividend Payout Ratio | - | - | - | - | - | 56.32% | 66.79% | 40.12% | 83.05% | - | - | - | 25.53% | 31.81% | 68.59% | 23.92% |
Structural demand and regulatory headwinds
As reported in recent financial filings, CSTE's top-line performance remains under pressure, with revenue declining 10.9% year-over-year in 2026Q1, marking a continuation of the persistent contraction trend that has plagued the company's core engineered stone business throughout the last ten quarters of observed data.
The consistent double-digit revenue declines suggest that the company is struggling to maintain its market position amidst a broader commoditization of the quartz category. This downward trajectory appears to be exacerbated by the company's reliance on the cyclical U.S. residential renovation market, where high interest rates continue to dampen consumer spending on high-end surface upgrades.
Based on the company's income statement data, gross margins have struggled to sustain levels above 20%, fluctuating between 15.5% and 24.5% over the past ten quarters, which highlights the significant difficulty in maintaining pricing power against lower-cost, imported engineered stone alternatives in the current environment.
The inability to consistently expand gross margins suggests that Caesarstone's brand equity is insufficient to offset the intense competitive pricing pressure. Investors should monitor whether the shift toward an asset-light manufacturing model can eventually stabilize these margins, or if the current cost structure remains fundamentally mismatched with the prevailing market pricing.
According to the provided income statement, CSTE has failed to achieve positive operating income in any of the last ten quarters, with operating margins reaching a low of -25.8% in 2023Q4, indicating a lack of operational scale and persistent inefficiencies in the company's current cost structure.
The persistent negative operating income suggests that the company's SG&A expenses are not scaling down in proportion to the revenue declines. This lack of operating leverage implies that the business model remains burdened by fixed costs or high overheads that have not yet been fully addressed by recent restructuring efforts.
As evidenced by the reported figures, net income has been consistently negative over the last ten quarters, with a significant outlier loss of $87.9 million in 2025Q4, suggesting that the bottom line is heavily impacted by non-recurring charges and structural impairments rather than core operational profitability.
The extreme volatility in net income, particularly the massive loss in 2025Q4, warrants further investigation into the nature of these one-time charges. Such results indicate that the reported EPS is currently an unreliable metric for assessing the company's underlying earnings power, as it is obscured by the ongoing costs of restructuring and potential asset write-downs.
Based on the recent operational context, the potential for regulatory contagion, exemplified by the Australian ban on high-silica surfaces, represents a critical threat that could render the company's core quartz product line obsolete in key global markets faster than the porcelain pivot can compensate.
Short-sellers would likely focus on the risk that the company's core quartz business faces an existential threat from health-related regulatory shifts. If this regulatory trend spreads to the U.S. or other major markets, the company's current turnaround strategy may prove insufficient to preserve the long-term viability of its primary revenue stream.
Quick answers to the most common questions about buying CSTE stock.
For fiscal year 2025, Caesarstone Ltd. (CSTE) reported total revenue of $397.2M. This represents a 53.0% increase compared to $259.7M in 2011.
Caesarstone Ltd. (CSTE) reported a net loss of $137.5M for the fiscal year ending 2025.
Caesarstone Ltd. (CSTE) reported an operating income of $-51.4M, resulting in an operating profit margin of -12.9%. This margin reflects the operational efficiency of the business before interest and taxes.
Caesarstone Ltd. (CSTE) generated $73.3M in gross profit for the year, representing a gross profit margin of 18.4%. This demonstrates the company's core pricing power and production efficiency.